中國光大控股(00165.HK)擬認購光大焦點收益基金權益
格隆匯 3 月 5日丨中國光大控股(00165.HK)發佈公吿,2021年3月4日,認購方(為公司的間接全資附屬公司)向基金經理遞交申請表格,據此,認購方同意遵守認購文件所載的條款,並以1500萬美元的認購金額認購該基金(即光大焦點收益基金)的I類美元單位。該基金由基金經理管理,基金經理為光大證券的全資附屬公司,而光大證券則為公司控股股東光大集團的附屬公司。
公吿表示,經參考該基金的投資目標以及基金經理豐富的經驗及技能,董事會相信認購事項與公司有關其財務投資組合的投資計劃及長期投資策略一致,而公司透過認購事項將能把握投資機遇及分散其投資組合。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.